Google Health is launching a free app that uses AI trained on more than 16,000 clinical dermatology cases and can identify hundreds of skin conditions, including cancers, with accuracy comparable to that of board-certified dermatologists in the U.S.

AI company Exscientia has received a vote of confidence approaching $1.2 billion in value from Bristol-Myers Squibb.

The profession of nursing is something of a sleeping giant within the global village of healthcare AI, according to an interdisciplinary collaborative of healthcare workers from North America and Europe.

A novel AI-based model for clinical decision support has bested established machine-learning models at predicting how patients with type-2 diabetes mellitus will respond to various categories of therapeutic drugs.

AI is poised to help settle an argument that’s been roiling academic psychiatry for more than a century: Are bipolar disorder and schizophrenia two distinct diagnoses—or points along a single continuum?

Biomedical and electrical engineers have invented a probe so small it must be inserted hypodermically yet can monitor vital signs and even stimulate tissue for therapeutic purposes.

Rensselaer Polytechnic Institute teamed up with clinicians at Massachusetts General Hospital to develop and test the deep learning tool.

The American Medical Association has launched a new initiative aimed at re-envisioning virtual care and ensuring that healthcare stakeholders understand its full potential.